Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine, and vaccines.
Baxter’s Medical Products business produces intravenous products and other products used in the delivery of fluids and drugs to patients; inhalational anaesthetics; contract manufacturing services; and products to treat end-stage kidney disease, or irreversible kidney failure, including products for peritoneal dialysis and hemodialysis.
Traded as: NYSE: BAX; S&P 500 component
Industry: Medical equipment
Founded: 1931; 89 years ago
Founder: Donald Baxter
Headquarters: Deerfield, Illinois, U.S.
Products: Medical supplies to treat hemophilia and kidney disease and provide intravenous therapy
Website: www.baxter.com